In March 2025, the company introduced new ideas for just a direct-to-buyer offering of its Wegovy weight loss drug. The company recognized a fresh pharmacy, called NovoCare, which would charge consumers $499 each month for access to the drug, below 50 % the expense of the drug via other pharmaceutical distribution networks.[53]inflammation within y